Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,125,784
Closed -$16.5M 4477
2025
Q3
$16.5M Sell
1,125,784
-6,653
-0.6% -$67.8K ﹤0.01% 1816
2025
Q2
$11.1M Buy
1,132,437
+46,973
+4% +$389K ﹤0.01% 2008
2025
Q1
$7.89M Buy
1,085,464
+230,677
+27% +$2.02M ﹤0.01% 2180
2024
Q4
$6.68M Buy
854,787
+60,075
+8% +$495K ﹤0.01% 2348
2024
Q3
$5.88M Buy
794,712
+70,848
+10% +$596K ﹤0.01% 2385
2024
Q2
$5.8M Buy
723,864
+9,333
+1% +$83.3K ﹤0.01% 2314
2024
Q1
$8.32M Buy
714,531
+96,530
+16% +$1.07M ﹤0.01% 2159
2023
Q4
$6.9M Buy
618,001
+37,339
+6% +$343K ﹤0.01% 2312
2023
Q3
$8.97M Buy
580,662
+21,030
+4% +$353K ﹤0.01% 2082
2023
Q2
$10.6M Buy
559,632
+458,040
+451% +$8.04M ﹤0.01% 2021
2023
Q1
$1.55M Buy
101,592
+37,266
+58% +$486K ﹤0.01% 3051
2022
Q4
$819K Sell
64,326
-4,351
-6% -$39.1K ﹤0.01% 3336
2022
Q3
$398K Buy
68,677
+34,001
+98% +$149K ﹤0.01% 3588
2022
Q2
$112K Sell
34,676
-63,891
-65% -$193K ﹤0.01% 4129
2022
Q1
$371K Sell
98,567
-3,823
-4% -$24.6K ﹤0.01% 3855
2021
Q4
$1.34M Sell
102,390
-882
-0.9% -$13.9K ﹤0.01% 3425
2021
Q3
$2.02M Sell
103,272
-18,142
-15% -$331K ﹤0.01% 3282
2021
Q2
$2.27M Buy
121,414
+269
+0.2% +$6K ﹤0.01% 3298
2021
Q1
$2.87M Sell
121,145
-18,740
-13% -$433K ﹤0.01% 3058
2020
Q4
$3.41M Buy
139,885
+26,486
+23% +$677K ﹤0.01% 2895
2020
Q3
$2.91M Buy
113,399
+32,132
+40% +$1.02M ﹤0.01% 2860
2020
Q2
$1.62M Buy
81,267
+38,323
+89% +$931K ﹤0.01% 3151
2020
Q1
$1.08M Buy
42,944
+13,130
+44% +$384K ﹤0.01% 3178
2019
Q4
$784K Buy
+29,814
New +$830K ﹤0.01% 3463

Other funds holding ETNB

Northern Trust's ETNB Position: Q4 2025 in Review

Northern Trust sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,125,784 shares — an estimated $16.5M sold.

Northern Trust first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $16.5M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Northern Trust reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Northern Trust sold 1,125,784 89bio shares in Q4 2025, an estimated $16.5M.
  • Northern Trust first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
  • Northern Trust's 89bio position peaked at $16.5M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.